SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Amrutanjan Healthcar - Quaterly Results

14 Feb 2023 Evaluate
The sales declined to Rs. 976.46 millions for the December 2022 quarter as compared to Rs. 1106.96 millions during the corresponding quarter last year.The Net Profit of the company slipped to Rs. 107.11 millions from Rs. 205.78 millions, a decline of -47.95% on QoQ basis.The Operating Profit of the company witnessed a decrease to 158.34 millions from 288.22 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 976.46 1106.96 -11.79 2793.19 2992.90 -6.67 4058.42 3328.44 21.93
Other Income 36.77 31.98 14.98 97.21 102.22 -4.90 153.83 113.20 35.89
PBIDT 158.34 288.22 -45.06 411.37 733.42 -43.91 948.56 860.73 10.20
Interest 0.16 0.30 -46.67 0.60 1.84 -67.39 4.85 5.00 -3.00
PBDT 158.18 287.92 -45.06 410.77 731.58 -43.85 943.71 855.73 10.28
Depreciation 13.14 8.77 49.83 39.02 26.02 49.96 37.95 36.70 3.41
PBT 145.04 279.15 -48.04 371.75 705.56 -47.31 905.76 819.03 10.59
TAX 37.93 73.37 -48.30 100.36 180.74 -44.47 233.88 207.14 12.91
Deferred Tax 0.00 0.00 0.00 -1.74 0.00 0.00 0.00 0.00 0.00
PAT 107.11 205.78 -47.95 271.39 524.82 -48.29 671.88 611.89 9.80
Equity 29.23 29.23 0.00 29.23 29.23 0.00 29.23 29.23 0.00
PBIDTM(%) 16.22 26.04 -37.72 14.73 24.51 -39.90 23.37 25.86 -9.62

Amrutanjan Healthcar Share Price

543.15 -3.35 (-0.61%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×